Virios Therapeutics (VIRI) Tops Q3 EPS by 20c; Reports Cash Position of $19.2M

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.49), $0.20 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
• UBS Reiterates Buy Rating on Comfort Systems USA (FIX) Amid Robust Demand Environment